Rho Chi Post

An award-winning, electronic, student-operated newsletter publication by the St. John's University College of Pharmacy and Health Sciences Rho Chi Beta Delta chapter

Menu

Skip to content
  • Home
  • Issues
    • Current Issue
    • All Issues
  • Articles
    • Featured
    • In the News / Politics
    • Events
    • Clinical
    • Advice / Opinions
    • Puzzles
    • Recently in PubMed
  • For Authors
    • Author Guidelines
    • AMA Citation Generator
    • Sign Up for Article(s)
    • Suggest Article(s)
    • Submit Article(s)
    • Check Statuses
    • Cite Your Article
  • About Us
    • About the Rho Chi Post
    • The Editorial Team
  • Apply for a Position
  • Subscribe
  • Login

Featured

Featured Articles

The Controversial use of Aducanumab (Aduhelm) for Alzhe...
February 1, 2022 - Clinical , Featured

By: Aamir S. Dave, PharmD Candidate c/o 2023 Judith L. Beizer, PharmD, BCGP, FASCP, AGSF Alzheimer’s and Dementia              Dementia is characterized by the loss of memory and other cognitive abilities that interfere with daily life. Alzheimer’s is a progressive neurological disease and is the most common type of dementia, accounting for greater than 60-80%…

Molnupiravir: A Prospective Oral Antiviral for Treatmen...
February 1, 2022 - Clinical , Featured

By: Justin Budz, PharmD Candidate c/o 2023              On January 19th, 2020, a 35-year-old man in an urgent care clinic in Snohomish County, Washington was the first to be confirmed by the Centers for Disease Control and Prevention (CDC) to be infected with Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2…

CDC Expands Eligibility for COVID-19 Booster Shots  ...
February 1, 2022 - Featured , In the News / Politics

By: Fatima Amjad, PharmD candidate c/o 2022              Pharmacists have truly taken on the role of superhero during the coronavirus disease 2019 (COVID-19) pandemic. As of April 6, 2022 more than 239.1 million COVID-19 vaccine doses have been administered by community pharmacies across the United States.1 Community pharmacists have gone above and beyond immunizing eligible…

A Review of A Randomized Trial of a Transglutaminase-2 ...
February 1, 2022 - Featured , In the News / Politics

By: Natalia Jucha, PharmD Candidate c/o 2022 and Helen Li, PharmD Candidate c/o 2023              Celiac disease is classified as an autoimmune disorder and occurs in individuals who cannot tolerate gluten. Dietary gluten induces an immune response and causes damage to the small intestine, particularly the duodenum and proximal jejunum. A small peptide called gliadin,…

Combating Chronic Diseases with a Plant-Based Diet...
December 1, 2021 - Clinical , Featured

By: Ashely Dao, PharmD Candidate c/o 2024               In early 2021, about 6 in 10 American adults had a chronic disease. Chronic diseases are the leading cause of death and disability in the United States with 1 in 3 deaths caused by cardiovascular diseases (CVD).¹ The Coronavirus disease 2019 (COVID-19) pandemic has emphasized the impact…

Good News, Bad News about Novel Treatment Resistant Dep...
December 1, 2021 - Featured , In the News / Politics

By: Daniel Levin, PharmD candidate c/o 2022               Depression is a terrible beast of an illness to battle with, and there are nearly 14 million individuals at any given moment fighting it. Only around 50% of patients struggling with depression will get some form of treatment. Sixty to seventy percent of patients who do get…

An Aspirin A Day Keeps the First Heart Attack Away… N...
December 1, 2021 - Featured , In the News / Politics

By: Jun Suh Hong, PharmD candidate c/o 2022               Aspirin belongs to a class of medications called nonsteroidal anti-inflammatory drugs (NSAIDS). Known by many for its analgesic and anti-inflammatory properties, as well as its association with gastrointestinal (GI) bleeding, aspirin plays an essential role in stroke prevention. As such, it has a crucial role in…

An Overview of Ketamine Cystitis...
December 1, 2021 - Clinical , Featured

By: Pallak Sharma, PharmD Candidate c/o 2022 and Mia Cord-Cruz, PharmD Candidate c/o 2022               Ketamine (Ketalar®) is currently approved by the Food and Drug Administration (FDA) for use as a general anesthetic, with additional indications listed within its package insert.1 Ketamine is a highly abused “street drug”, especially in China. To demonstrate, in Hong…

Cabenuva: A Monthly Injectable for the Treatment of HIV...
December 1, 2021 - Featured , In the News / Politics

By: Sharon Joseph PharmD Candidate c/o 2022 and Salma Hewady, PharmD               Human immunodeficiency virus (HIV) is a single-stranded retrovirus that attacks the immune system, predisposing the host to opportunistic infections and malignancies. If not properly treated, HIV can progress to Acquired Immunodeficiency Syndrome (AIDS). Goals of therapy include restoration of immune function, suppression of…

Understanding the MELD and PELD Score and Its Role In L...
October 1, 2021 - Clinical , Featured

By: Jason Ifeanyi, PharmD Candidate c/o 2022               The liver is one of the most commonly transplanted solid organs in the United States (US) today. The United Network for Organ Sharing (UNOS) is a mission-driven non-profit that leads the network of transplant hospitals, organ procurement organizations, and thousands of volunteers who are dedicated to saving…

Ranitidine (Zantac®) Making a Comeback...
October 1, 2021 - Featured , In the News / Politics

By: Mandy Zheng, PharmD Candidate c/o 2024               “Where can I find Zantac?”. From April 2020 to May 2021, the answer was, you cannot. On April 1, 2020, the Food and Drug Administration (FDA) ordered for all ranitidine (Zantac®)- containing products to be removed from the U.S. market.¹ Ranitidine was a popular over-the-counter (OTC) and…

Opioid Addiction During a Public Health Crisis...
October 1, 2021 - Featured , In the News / Politics

By: Anjali Rana, PharmD Candidate c/o 2025 and Katharine Russo, PharmD               The Coronavirus disease 2019 (COVID-19) pandemic continues to pose challenges, both nationally and worldwide. Many countries that were facing public health crises prior to COVID-19 have subsequently seen a worsening of these crises, as much of the funding and attention previously available has…

CAR T-cell therapy for Multiple Myeloma...
August 1, 2021 - Featured , In the News / Politics

By: Lyana Sayilar, PharmD Candidate c/o 2022               Multiple myeloma is characterized by an accumulation of abnormal plasma cells in the bone marrow and the formation of tumors in bones. An insufficient quantity of healthy blood cells are produced in the bone marrow leading to a weakened immune system.1 The exact cause of multiple myeloma…

Potentially Life-Threatening Interactions Between Newer...
August 1, 2021 - Featured , In the News / Politics

By: Richa Tamakuwala, PharmD Candidate c/o 2022               There has been a dramatic rise in the number of patients with cardiovascular implantable electronic devices (CIEDs), such as permanent pacemakers and implantable cardioverter‐defibrillators (ICDs), due to an increasing aging population and clinical trials showing benefits in mortality and morbidity.  Multiple studies investigating the use of ICDs…

Dravet’s Syndrome and a Novel Antiepileptic Drug: Can...
August 1, 2021 - Clinical , Featured

By: Jason Ifeanyi, PharmD Candidate c/o 2022               Epilepsy is a highly prevalent neurological disorder caused by unusual nerve cell activity, and is among one of the most common disease states encountered today in clinical practice. Each year around 150,000 Americans are diagnosed with epilepsy.1 Epilepsy is defined by the World Health Organization (WHO) as…

Pharmaceutical Breakthrough for the Treatment of Duchen...
June 1, 2021 - Featured , In the News / Politics

By: Rubab Hassan, PharmD Candidate c/o 2022              Duchenne muscular dystrophy (DMD) is a genetic disorder that causes muscle degeneration and weakness along with various other symptoms. It is predominantly caused by deletions of one or more exons, which lead to mutations of the dystrophin gene. Dystrophin stops muscle fibers from being degraded by proteases.…

Emerging Frontiers in Multiple Myeloma Pharmacotherapy...
June 1, 2021 - Clinical , Featured

By: Nishanth Viswanath, PharmD Candidate c/o 2022              Multiple myeloma (MM)  is a hematological malignancy characterized by an accumulation and proliferation of monoclonal plasma cells in the bone marrow. 1 Throughout the course of the disease, malignant plasma cells induce an overproduction of non-functional immunoglobulin (paraproteins), which is evident during urine and blood screenings. 2…

Desmopressin Challenge for Von Willebrand’s Disease i...
June 1, 2021 - Featured , In the News / Politics

By: Oluwafemi Popoola, PharmD Candidate c/o 2021, SUNY Binghamton School of Pharmacy & Pharmaceutical Sciences              A patient with past medical history of von Willebrand’s disease (VWD) and myasthenia gravis on chronic prednisone therapy, presented for follow-up for VWD at the hematology/oncology clinic. The provider considered having the patient undergo a “desmopressin challenge” with desmopressin…

Correlation of Salt-Intake and Hypertension...
June 1, 2021 - Featured , In the News / Politics

By: Jordan Plair, PharmD Candidate c/o 2022 and Marina Beshara, PharmD Candidate c/o 2022              While the focus over the last year has been fixated on the deadly coronavirus, the importance of a long-standing health pandemic exacerbated by salt intake cannot be overlooked. Hypertension, more commonly referred to as high blood pressure, is a medical…

FDA approves Vibegron (Gemtesa®) for the Treatment of ...
June 1, 2021 - Featured , In the News / Politics

By: Arya Firoozan, PharmD Candidate c/o 2023              Overactive bladder (OAB) is a condition that causes a sudden and frequent urge to urinate. It is also associated with incontinence and nocturia. Nocturia refers to waking up at night due to the urge to urinate. OAB is diagnosed if there is no other current infection or…

Connecting the Dots: Ankylosing Spondylitis and Heart D...
June 1, 2021 - Featured , In the News / Politics

By: Jennifer Galvet, PharmD Candidate c/o 2024              Ankylosing spondylitis (AS) is a systemic inflammatory condition that primarily affects a person’s back.¹ It is a form of arthritis that affects the spine and causes inflammation of the spinal joints, leading to severe, chronic pain and discomfort.² Ankylosing spondylitis can also impact other areas of the…

Bamlanivimab for the treatment of COVID-19...
April 1, 2021 - Featured , In the News / Politics

By: Daniela Farzadfar, PharmD,PGY-1 Resident at Long Island Jewish Medical Center              In March 2020, the World Health Organization (WHO) declared coronavirus disease- 2019 (COVID-19) a global pandemic. 1 To date, over 30 million cases of COVID-19 have been reported in the United States and drug companies have been scrambling to develop therapies for the…

Insulin Monitoring System for Pediatric patients...
April 1, 2021 - Featured , In the News / Politics

By: Lyana Sayilar, PharmD Candidate c/o 2022              On August 31, 2020, the FDA approved the first automated diabetes management device for patients aged 2 to 6-years old. The MiniMed 770G System automatically adjusts basal insulin doses based on glucose levels, facilitating the lives of the patient and caregiver. Prior to its approval, patients and/or…

Who is COVID-19 hitting the hardest?...
April 1, 2021 - Featured , In the News / Politics

By: Pooja Dasgupta and Sonya Wadhawan, PharmD Candidates c/o 2025              The coronavirus, also known as SARS CoV-2 or COVID-19, has widely affected various people globally. The study of SARS CoV-2 has shifted from studying individuals and their unique symptoms during their disease duration to studying different populations and their backgrounds that increase the risk…

The Cardiovascular Effects of Cannabis vs. Tobacco Cons...
April 1, 2021 - Clinical , Featured

By: Jeng Lee, PharmD Candidate c/o 2022               Throughout the past decade, there has been an increase in the prevalence of medical and recreational consumption of cannabis, also referred to as marijuana. 1 These numbers are expected to rise over the upcoming years in the United States as marijuana use is currently legalized in 33…

New Drug Update: Lemborexant (Dayvigo ®)...
April 1, 2021 - Clinical , Featured

By: Cindy Van, PharmD Candidate c/o 2022, Shireen Farzadeh, PharmD, BCPS              Insomnia is a condition characterized by difficulty falling asleep, staying asleep, or both, despite an adequate opportunity to sleep. Consequently, insomnia can lead to daytime fatigue, difficulty concentrating, and irritability. This condition can be categorized into short-term and chronic insomnia. While short-term insomnia…

Rybelsus: Novel Oral GLP-1 Agonist and the Future of Or...
April 1, 2021 - Clinical , Featured

By: Tanay Maddula PharmD Candidate c/o 2022               Rybelsus (oral semaglutide) was recently approved by the Food and Drug Administration (FDA) in September 2019 to help control blood sugar in adult patients with Type 2 Diabetes alongside diet and exercise. It is the first oral GLP-1 (glucagon like peptide-1) agonist as typical drugs of this…

Fostemsavir: New drug for the treatment of HIV-1 resist...
April 1, 2021 - Featured , In the News / Politics

By: Bisma Sekhery, PharmD Candidate c/o 2021              Fostemsavir (Rukobia) is a new Food and Drug Administration (FDA) approved antiretroviral agent for the treatment of Human Immunodeficiency Virus (HIV). It was approved in July 2020 for multidrug-resistant HIV-1. It is a pro-drug, metabolized to its active moiety, temsavir, which binds to the gp120 subunit within…

Emerging Type 3 Diabetes...
April 1, 2021 - Clinical , Featured

By: Zarnab Jillani PharmD Candidate c/o 2022              The link between diabetes and Alzheimer’s disease (AD) is a new and ongoing debate given the etiology of AD is still not fully understood. Diabetes continues to be a major public health crisis as diagnoses around the world continue to rise. Diabetes is a chronic disease that…

Increasing Evidence of the Benefits of Statins...
April 1, 2021 - Clinical , Featured

By: Pallak Sharma, PharmD Candidate c/o 2022 and Rebecca Samuel, PharmD Candidate c/o 2022              Statins, some of the most well-known cholesterol lowering medications, have been demonstrating increasing evidence of safety and benefits to the elderly patient population. 5 Statins are a class of medication that can help lower the level of low-density lipoprotein (LDL)…

AstraZeneca Sells Rights to Two Cardiovascular Drugs fo...
April 1, 2021 - Featured , In the News / Politics

By: Jennifer Galvet, PharmD Candidate c/o 2024 Introduction The British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca has agreed to sell its rights to two cardiovascular drugs to Germany’s Cheplapharm Arzneimittel GmbH for $400 million. This decision allows AstraZeneca to reinvest in the company’s main areas of focus: cardiovascular, renal and metabolism, cancer, respiratory, inflammation and…

Daniel Schneider RPh.’s crusade against OxyContin...
February 1, 2021 - Featured , In the News / Politics

By: Alisha Kuriakose, PharmD Candidate c/o 2022 “The Pharmacist” is a Netflix documentary that showcases pharmacist Dr. Daniel Schneider’s crusade against OxyContin® abuse. It highlights his discovery of a corrupt doctor who exploited her medical license and destroyed communities in Louisiana. It also illustrates his fight to expose Purdue Pharma of falsely reporting the addictive…

EndeavourRx ™: The Prescription-Only, FDA-Approved Vi...
February 1, 2021 - Featured , In the News / Politics

By: Aiśa Mrkulic PharmD Candidate c/o 2022              Attention Deficit Hyperactivity Disorder (ADHD) is one of the most common reasons children require referrals for mental health services.¹ In fact, the American Academy of Pediatrics (AAP) recommends the screening of every child with ADHD for neuropsychiatric comorbidities. With, “one in every 20 children affected,” it exists…

FDA Approves GlaxoSmithKline’s Combined Formulation o...
February 1, 2021 - Featured , In the News / Politics

By: Edwin Gruda, PharmD Candidate c/o 2022; Aiśa Mrkulic, PharmD. Candidate c/o 2022              Over-the-Counter (OTC) medications are typically used for mild pain relief. Many patients rely on their OTC medications to treat headaches, fevers, muscle pain, tooth aches and mild arthritis. In March of 2020, the Food and Drug Administration (FDA) approved a new…

NMOSD Treatment...
February 1, 2021 - Featured , In the News / Politics

By: Lyana Sayilar PharmD. Candidate c/o 2022              Neuromyelitis optica spectrum disorder (NMOSD) is a rare disorder affecting 4,000 to 8,000 Americans. Adults with this disorder are often found to have anti-aquaporin-4 (AQP4)antibodies that primarily attack healthy cells and proteins in the optic nerves and spinal cord. The majority of patients have relapses within three…

Dangers of the High-Sodium Diet...
February 1, 2021 - Featured , Professional Advice / Opinions

By: Anjali Rana PharmD. Candidate c/o 2025              While too much of any food or substance is not good, sodium-rich diets are especially harmful to the body causing increases in blood pressure and fluid retention. Sodium is found in majority of the foods consumed. People should be cautious of processed goods and restaurant meals which…

Use of dexamethasone for the treatment of COVID-19: an ...
February 1, 2021 - Clinical , Featured

By: Bisma T. Sekhery PharmD. Candidate c/o 2025              COVID-19 has had a significant impact on the health, economic, and social aspects of life for every person. Currently, there is only one Food and Drug Administration (FDA)-approved treatment for COVID-19–remdesivir (Veklury®). The lack of approved therapies makes COVID-19 difficult to treat and increases overall mortality…

Flu Shot Season, COVID-19 and How Pharmacies are Bracin...
February 1, 2021 - Featured , In the News / Politics

By: Rebecca Samuel, PharmD Candidate c/o 2022 and Pallak Sharma, PharmD Candidate c/o 2022              It is flu shot season! That’s a phrase that causes almost every pharmacy staff member to take a deep breath. Amid the pandemic, flu shot season is busier than ever and it is directly affecting pharmacies across the country. In…

Transition of Care: A New and Emerging Pharmacy Special...
December 1, 2020 - Featured , Professional Advice / Opinions

By: Sami Barakat, PharmD. and Natalia Jucha, PharmD. Candidate c/o 2022              Since the publication of the Institute of Medicine report To Err is Human: Building a Safer Health System, there has been a growing movement to improve patient safety. The report revealed that more than 7000 deaths occur annually due to medication errors.1 It…

Vancomycin Monitoring for Serious MRSA Infections in Ad...
December 1, 2020 - Clinical , Featured

By: Darien Lee, Pharm D Candidate c/o 2021              Vancomycin, a glycopeptide antibiotic, is one of the most commonly used medications in hospitals. Its widespread use is attributed to its efficacy for the treatment and prevention of bacterial infections caused by gram-positive bacteria. One of its most notable features is its coverage of methicillin-resistant Staphylococcus…

Antibiotic Resistance: Why It’s Important to Educate ...
December 1, 2020 - Featured , Professional Advice / Opinions

By: Natalia Jucha PharmD Candidate c/o 2022              Due to the overuse and misuse of these medications, antibiotics are no longer as effective against their intended pathogens.1 In 2019, the World Health Organization (WHO) released its AWaRE Classification Database which stands for “Access, Watch and Reserve”.2 Clinicians use this database as a guide to appropriately…

Next Up in the World of Hyperlipidemia: Nexletlol TM...
December 1, 2020 - Featured , In the News / Politics

By: Preethi Samuel, Pharm.D. Candidate c/o of 2021              In the United States, at least one person has a heart attack every 40 seconds and 1 of every 5 is silent.1 Heart attacks are commonly a result of atherosclerotic cardiovascular disease (ASCVD). Preceding plaque buildup in arterial walls can potentially lead to a heart attack…

Asthma, Alveoli, and Albuterol: A General Overview of A...
December 1, 2020 - Clinical , Featured

By: Jeremy Mesias, PharmD Candidate c/o 2022              It starts with a simple cough or a wheeze. Suddenly, it escalates to tightness in the chest. Breathing gets quicker but shallower, making you feel short of breath. These are the most common and recognizable symptoms of an asthma attack.  Around the world, nearly 300 million people…

MIS-C: The Impact of COVID-19 on the Pediatric Populati...
December 1, 2020 - Featured , In the News / Politics

By: Erica Tonti, PharmD Candidate c/o 2022 Multisystem Inflammatory Syndrome in Children, or MIS-C, is a recent syndrome recognized by the Centers for Disease Control and Prevention (CDC). The emergent outbreak of COVID-19 brought concern as to who would be affected by MIS-C and how severe the impact of the syndrome would be. Children, thought to…

A New Drug Class for Heart Failure—Dapagliflozin’s ...
December 1, 2020 - Featured , In the News / Politics

By: Adrian Wong, PharmD Candidate c/o 2021 On May 5, 2020, the Food and Drug Administration (FDA) announced its approval for Farxiga® (dapagliflozin) oral tablets to have a new indication: to lower the risk of cardiovascular death and hospitalization for adults with New York Heart Association (NYHA) functional class II-IV heart failure (HF) with reduced…

Provider Status: What is it?...
October 1, 2020 - Featured , In the News / Politics

By: Katharine Russo, PharmD Candidate c/o 2021              As of July 1, 2000, the Accreditation Council for Pharmacy Education (ACPE) mandated for the Doctor of Pharmacy (PharmD) degree to be the sole degree required to enter pharmacy practice in the United States. ¹ With this advanced degree came the complex education, training, and clinical practice…

The Psychological impact of COVID-19 on Mental Health &...
October 1, 2020 - Featured , In the News / Politics

By: Shea Dorsey, PharmD Candidate c/o 2021            COVID-19 has taken a major toll on the mental wellbeing of people around the world and continues to do so today, almost 7 months after the United States first announced quarantine. Many individuals previously diagnosed with an anxiety disorder, depressive disorder, trauma-and stressor-related disorder (TSRD) or expressed…

New York State and Provider Status...
October 1, 2020 - Featured , In the News / Politics

By: Mah Noor, PharmD Candidate c/o 2021              Over the past decade, pharmacists across the nation have joined in a number of grassroots efforts to gain legislative recognition as health care providers. As of 2019, thirty-four states have recognized pharmacists as providers in at least one section of their state statute or in their state…

The State of Pharmacy Advocacy in New York...
October 1, 2020 - Featured , In the News / Politics

By: Jeremy Mesias, PharmD Candidate c/o 2022            As we begin another October, we mark the start of American Pharmacist Month and celebrate pharmacists and their work around the country. We are also reminded of the great leaps and bounds our profession has made over the years to advance patient care. Behind all great progress,…

Pharmacists for Black Lives...
October 1, 2020 - Featured , Professional Advice / Opinions

By: Aiša Mrkulić , PharmD Candidate c/o 2022              In fulfilling our vow to uphold the Oath of a Pharmacist, we must regard, “the welfare of humanity and relief of suffering” as our top priority. Voluntary are the promises which accompany this oath, promises with wellness at their forefront. ² It is not without reason…

Post navigation

← Older posts


Do You Want to be a Published Author? Submit your Article(s) Today!



Tweets by @RhoChiPost

HOME: Home Page

VOLUMES / ISSUES: 11 . 10 . 9 . 8 . 7 . 6 . 5 . 4 . 3 . 2 . 1

ARTICLES: Featured . In the News / Politics . Events . Clinical . Advice / Opinions . Puzzles

FOR AUTHORS: Guidelines . AMA Citation Generator . Sign Up . Suggest . Submit . Cite

ABOUT US: About the Rho Chi Post . The Editorial Team . Apply for a Position

SUBSCRIBE: Google Groups Email List


Copyright © 2011-2022 Rho Chi Post